Workflow
CCEM(300655)
icon
Search documents
晶瑞电材(300655) - 2024年年度权益分派实施公告
2025-05-27 09:46
债券代码:123031 债券简称:晶瑞转债 | 公告编号:2025-060 | | --- | | 证券简称:晶瑞电材 | | 证券代码:300655 | 1 2、根据《公司法》《上市公司股份回购规则》《深圳证券交易所上市公司自律 监管指引第9号——回购股份》等规定,上市公司回购专用账户中的股份不享有参 与利润分配的权利。因此,公司本次实际现金分红总额=剔除回购证券专户后的公 司总股本×每股现金分红比例=1,057,684,614股×0.045元/股= 47,595,807.63元(含税); 按公司总股本(含回购证券专户股份,下同)折算的每10股现金分红金额=本次实 际现金分红总额 / 公 司 总 股 本 *10 股 =47,595,807.63 元 /1,059,571,989 股 *10 股 =0.449198元(含税,保留6位小数,最后一位直接截取,不四舍五入) 3、本次权益分派实施后的除权除息参考价格=除权除息前一交易日收盘价﹣ 按公司总股本折算每股现金分红比例=除权除息前一交易日收盘价-0.0449198元/股。 债券代码:123124 债券简称:晶瑞转 2 晶瑞电子材料股份有限公司 2024 年年 ...
晶瑞电材(300655) - 关于晶瑞转债、晶瑞转2转股价格调整的公告
2025-05-27 09:46
| 公告编号:2025-061 | | --- | | 证券简称:晶瑞电材 | | 证券代码:300655 | 债券代码:123031 债券简称:晶瑞转债 债券代码:123124 债券简称:晶瑞转 2 晶瑞电子材料股份有限公司 关于"晶瑞转债"、 "晶瑞转 2"转股价格调整的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有 虚假记载、误导性陈述或重大遗漏。 特别提示: 1、本次调整前"晶瑞转债"的转股价格为3.83元/股,本次调整后"晶瑞转债" 的转股价格为3.79元/股; 2、本次调整前"晶瑞转2"的转股价格为16.74元/股,本次调整后"晶瑞转2"的 转股价格为16.70元/股; 3、本次转股价格调整实施日期均为2025年6月4日。 一、可转换公司债券发行上市基本情况 (一)"晶瑞转债"发行上市基本情况 1、经中国证券监督管理委员会(以下简称"中国证监会")"证监许可 [2019]687号"文核准,苏州晶瑞化学股份有限公司(已更名为晶瑞电子材料股份 有限公司,以下简称"公司")于2019年8月29日向社会公开发行185万张可转换 公司债券(以下简称"可转债"),每张面值100元,发行总 ...
晶瑞电材: 关于晶瑞转债、晶瑞转2 暂停转股的提示性公告
Zheng Quan Zhi Xing· 2025-05-22 14:13
Core Points - The company announces a temporary suspension of the conversion of its convertible bonds "Jingrui Convertible Bond" and "Jingrui Convertible Bond 2" from May 23, 2025, until the annual equity distribution registration date in 2024 [1][2] - The conversion period for "Jingrui Convertible Bond 2" is from February 21, 2022, to August 15, 2027 [1] - The company will issue an announcement regarding the implementation of the 2024 annual equity distribution soon [1] Summary by Sections Announcement Details - The company guarantees that the information disclosed is true, accurate, and complete, with no false records or misleading statements [1] - During the suspension period, both convertible bonds will continue to trade normally [2] Conversion Price Adjustment - The adjustment of the conversion price will occur if the company distributes stock dividends, increases capital, issues new shares, or distributes cash dividends [4][6] - Specific formulas for adjusting the conversion price are provided, including scenarios for stock dividends, new share issuance, and cash dividends [4][6] - The company will publish announcements regarding conversion price adjustments in accordance with relevant regulations [5][7]
晶瑞电材(300655) - 关于晶瑞转债、晶瑞转2 暂停转股的提示性公告
2025-05-22 12:18
| | | 债券代码:123031 债券简称:晶瑞转债 债券代码:123124 债券简称:晶瑞转 2 晶瑞电子材料股份有限公司 关于"晶瑞转债"、 "晶瑞转 2"暂停转股的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 特别提示: 1、债券代码:123031 债券简称:晶瑞转债 债券代码:123124 债券简称:晶瑞转2 2、"晶瑞转债"的转股期限:2020年3月5日至2025年8月28日 "晶瑞转2"的转股期限:2022年2月21日至2027年8月15日 3、"晶瑞转债"、"晶瑞转2"计划暂停转股时间:2025年5月23日至2024年年 度权益分派股权登记日止 4、"晶瑞转债"、"晶瑞转2"计划恢复转股时间:2024年年度权益分派股权 登记日后的第一个交易日 晶瑞电子材料股份有限公司(原名苏州晶瑞化学股份有限公司,以下简称"公 司")将于近日发布2024年年度权益分派实施公告,根据《苏州晶瑞化学股份有 限公司创业板公开发行可转换公司债券募集说明书》、《晶瑞电子材料股份有限公 司创业板向不特定对象发行可转换公司债券募集说明书》中"转股价格的调整方 ...
晶瑞电材: 向不特定对象发行可转换公司债券受托管理事务报告(2024年度)
Zheng Quan Zhi Xing· 2025-05-16 13:40
Group 1 - The company, Crystal Clear Electronic Material Co., Ltd., issued convertible bonds totaling RMB 523 million, approved by the board and shareholders [2][3][25] - The net proceeds from the bond issuance amounted to RMB 514.70 million after deducting underwriting fees [3][23] - The bonds have a maturity period of 6 years, with an annual interest rate starting at 0.2% in the first year and increasing to 2.0% in the sixth year [4][5][25] Group 2 - The company achieved significant operational results, breaking the long-standing technological and market monopolies of international giants in the semiconductor high-purity chemical sector [18][19] - The company reported a revenue increase of 10.44% year-on-year, reaching RMB 1.44 billion, with a significant rise in operating cash flow by 81.13% [19][20] - The company has established itself as a leading supplier in the domestic market, with over 40% market share in high-purity hydrogen peroxide [18][19] Group 3 - The company faced its first loss since listing, with a net profit attributable to shareholders of -RMB 179.59 million due to significant goodwill impairment and increased R&D expenses [20][21] - R&D expenses grew by 39.74%, reflecting the company's commitment to innovation and product development [21][22] - The company maintains a strong competitive position in the industry, with no significant adverse changes in its core business or market conditions [21][22] Group 4 - The company has a robust plan for utilizing the raised funds, focusing on high-end product development and capacity expansion [23][24] - The company has adjusted the implementation of certain projects to optimize resource allocation and achieve strategic business integration [23][24] - The company has not provided any guarantees for the bonds, which may increase repayment risks if significant negative events occur [25]
晶瑞电材: 2024年年度股东大会的法律意见书
Zheng Quan Zhi Xing· 2025-05-16 13:30
Core Viewpoint - The legal opinion from Beijing Wan Shang Tian Qin Law Firm confirms that the 2024 Annual General Meeting of Crystal Ray Electronic Materials Co., Ltd. was convened and conducted in accordance with relevant laws and regulations, with all resolutions passed being valid and effective [12]. Group 1: Meeting Procedures - The annual general meeting was convened by the company's board of directors, scheduled for May 16, 2025, at 14:30, with prior notification published on April 24, 2025 [2][3]. - The meeting utilized a combination of on-site voting and online voting, with specific time slots for online voting detailed [3][4]. Group 2: Attendance and Voting Results - A total of 316 shareholders and their representatives attended the meeting, representing 175,945,188 shares, which is 16.6054% of the total shares [4]. - The voting results for the 10 resolutions presented at the meeting showed overwhelming support, with the majority of votes in favor exceeding 99% for each resolution [5][6][7][9][11]. Group 3: Legal Compliance - The qualifications of the meeting attendees, the convenor, and the voting procedures were all verified to comply with legal and regulatory requirements, ensuring the legitimacy of the meeting [12].
晶瑞电材(300655) - 向不特定对象发行可转换公司债券受托管理事务报告(2024年度)
2025-05-16 12:21
证券代码:300655 证券简称:晶瑞电材 债券代码:123031 债券简称:晶瑞转债 债券代码:123124 债券简称:晶瑞转 2 1 晶瑞电子材料股份有限公司 向不特定对象发行可转换公司债券 受托管理事务报告 (2024 年度) 债券受托管理人 (深圳市红岭中路 1012 号国信证券大厦 16-26 层) 二〇二五年五月 重要声明 本报告依据《可转换公司债券管理办法》(以下简称"《管理办法》")《苏州 晶瑞化学股份有限公司向不特定对象发行 2021 年可转换公司债券之受托管理协 议》(以下简称"《受托管理协议》")《晶瑞电子材料股份有限公司创业板向不特 定对象发行可转换公司债券募集说明书》(以下简称"《募集说明书》")《晶瑞电 子材料股份有限公司 2024 年年度报告》等相关公开信息披露文件、第三方中介 机构出具的专业意见等,由本期债券受托管理人国信证券股份有限公司(以下简 称"国信证券")编制。国信证券对本报告中所包含的从上述文件中引述内容和 信息未进行独立验证,也不就该等引述内容和信息的真实性、准确性和完整性做 出任何保证或承担任何责任。 本报告不构成对投资者进行或不进行某项行为的推荐意见,投资者应对 ...
晶瑞电材(300655) - 2024年年度股东大会的法律意见书
2025-05-16 12:19
北京市万商天勤律师事务所 关于 晶瑞电子材料股份有限公司 2024 年年度股东大会的法律意见书 北京市朝阳区建国门外大街 8 号北京国际财源中心 A 座 32 层 100022 电话:+86 10 82255588 www.vtlaw.cn 北京 深圳 上海 成都 武汉 西安 长沙 杭州 海口 南京 广州 昆明 福州 重庆 天津 合肥 香港(联营) 北京市万商天勤律师事务所 关于晶瑞电子材料股份有限公司 2024 年年度股东大会的法律意见书 致:晶瑞电子材料股份有限公司 根据《中华人民共和国证券法》《中华人民共和国公司法》及中国证券监督管理委 员会《上市公司股东会规则》(以下称"《股东会规则》")等法律、法规和规范性文件 的规定,北京市万商天勤律师事务所(以下称"本所")接受晶瑞电子材料股份有限公 司(以下称"公司")的委托,指派律师参加公司 2024 年年度股东大会,并出具法律 意见。 本所律师同意将本法律意见书随公司本次股东大会决议一并予以公告,并依法对 本法律意见书承担相应的责任。 本所律师根据《股东会规则》第五条的要求,按照律师行业公认的业务标准、道 德规范和勤勉尽责精神,对公司提供的有关文件和本次股 ...
晶瑞电材(300655) - 300655晶瑞电材投资者关系管理信息20250509
2025-05-09 13:23
Group 1: Financial Performance - The net profit of Hubei Jingrui from January to October 2024 was -15.49 million CNY, but the annual report forecasts a year-on-year growth of 540% in net profit attributable to shareholders [3] - R&D expenses for 2024 are projected to reach 99.24 million CNY, reflecting a year-on-year increase of 39.74% [4] Group 2: Production Capacity and New Projects - The new production line for high-purity hydrogen peroxide is expected to be completed by the end of June 2025, with construction progress on track [3] - The company aims to enhance the shipment levels and market share of high-purity hydrogen peroxide post the new production line launch [4] Group 3: Market Strategy and Competition - The company plans to improve gross profit margins through various strategies, including increasing self-supply levels of raw materials and enhancing product sales [3] - The penetration rate of high-purity chemicals in advanced processes (14nm and below) is gradually increasing [3] Group 4: R&D Focus and Product Development - The company is intensifying R&D investments in high-end photoresists and high-purity chemicals, with a nearly 40% increase in R&D spending [3] - The company has no current plans to expand into the new energy materials sector [4]